The chromium(III)-quinolinato complexes, [Cr(quinH) 3 ] 0 , [Cr(quinH) 2 (H 2 O) 2 ] + and [Cr(quinH)(H 2 O) 4 ] 2+ (where quinH = N,O-bonded quinolinic acid anion), were obtained and characterized in solution. The tris-quinolinato complex undergoes acid-catalyzed aquation to give the diaqua-product, whereas subsequent ligand liberation processes are exceptionally slow. Kinetics of the aquation were studied spectrophotometrically over the 0.1-1.0 M HClO 4 range, at I = 1.0 M. The first aquation stage, the chelate-ring opening at the Cr-N bond, is much faster than the second one. The following rate laws were established: k obs = k 1 + k )1 /Q 1 [H + ] and k obs = k 2 Q 2 [H + ]/(1 + Q 2 [H + ]), where k 1 and k 2 are the rate constants for the chelate-ring opening and the ligand liberation, respectively, k )1 is the rate constant of the chelate-ring closure, Q 1 and Q 2 are the protonation constants of the pyridine nitrogen and 3-carboxylate group in the one-end bonded intermediate, respectively. Kinetic parameters have been determined and the mechanism has been discussed.
The chromium(III) complexes with a new potential chromium transporting ligand-2,5-pyridinedicarboxylic acid (isocinchomeronic acid, icaH 2 ):[Cr(icaH) 3 ] 0 , [Cr(icaH) 2 (H 2 O) 2 ] + and [Cr(icaH)(H 2 O) 4 ] 2+ (where icaH = N,O-bonded isocinchomeronic acid anion), have been obtained and characterized in solution. The [Cr(icaH) 3 ] 0 complex undergoes aquation in acidic media to the diaquaproduct. Kinetics of this process was studied spectrophotometrically in the 0.1-1.0 M HClO 4 range, at I = 1.0 M. The first aquation stage, the chelate-ring opening at the Cr-N bond, is a much faster than the second one. The rate laws are of the form: k obs = k 1 + k -1 /Q 1 [H + ] and k obs = k 2 Q 2 [H + ]/ (1 + Q 2 [H + ]), where k 1 and k 2 are the rate constants for the chelate-ring opening and the ligand liberation, respectively, k -1 is the rate constant of the chelate-ring closure, Q 1 and Q 2 are the protonation constants of the pyridine nitrogen and 5-carboxylate group in the one-end bonded intermediate, respectively. The results are discussed in terms of potential pharmaceutical application of the complex.
Two complexes, 3 ] 0 and [Cr(2-hnic) 3 ] 0 (where 3-hpic = hydroxypicolinic acid and 2-hnic = 2-hydroxynicotinic acid anions), were prepared and characterized in solution. The 3-hpic ligand forms a 5-membered chelate ring via pyridine nitrogen and carboxlate oxygen atoms, whereas the 2-hnic ligand forms a 6-membered chelate ring via carboxylate and phenolate oxygen atoms. The kinetics of the acid-catalyzed aquation were studied spectrophotometrically in the 0.1-1.0 M HClO 4 range, at I ¼ 1:0 M . The rate equations for the first aquation step -the chelate-ring opening -was determined and a mechanism was proposed. In the case of [Cr(3-hpic) 3 ] 0 , the reversible chelate-ring opening at the CrAN bond precedes much slower than the second aquation step -a one-end bonded ligand liberation. The equation rate is of the form: k obs ¼ k 1 þ k À1 =Q 1 [H þ ], where k 1 and k À1 are the rate constants for the forward and the reverse processes in the unprotonated substrate and Q 1 is the protonation constant of the non-bonded pyridine nitrogen atom. In the case of [Cr(2-hnic) 3 ] 0 , the chelate-ring opening at the CrAO (phenolate) bond is the rate-determining step. The observed pseudo-first order rate constant increases as [H þ ] increases:where k 0 and k H are the rate constants of the spontaneous and acid catalyzed processes and Q H is the protonation constant of the coordinated phenolate oxygen atom. The results lead to the conclusion that an aquation mechanism depends on the coordination mode of the ligand.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.